Stay updated on HMPL-689 in Lymphomas: Failed Standard - Clinical Trial

Sign up to get notified when there's something new on the HMPL-689 in Lymphomas: Failed Standard - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HMPL-689 in Lymphomas: Failed Standard - Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The record describes a completed Phase 1 study of HMPL-689 in patients with lymphoma, including its design, eligibility criteria, treatment arms, outcomes, and study locations in China.
    Difference
    48%
    Check dated 2026-11-08T05:38:08.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T02:42:33.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T02:41:42.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site's displayed revision number changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T02:33:00.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision number was updated from v3.7.0 to v3.7.1; the study page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T02:39:06.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the usual study details. This indicates restricted access to the record, preventing viewers from accessing the study information on the page.
    Difference
    18%
    Check dated 2026-09-20T01:37:54.000Z thumbnail image

Stay in the know with updates to HMPL-689 in Lymphomas: Failed Standard - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HMPL-689 in Lymphomas: Failed Standard - Clinical Trial page.